On Tuesday, BofA Securities revised its price target for American Healthcare REIT, Inc (NYSE:AHR), increasing it to $27 from the previous $19 while retaining a Buy rating on the stock. The adjustment follows recent management meetings with the company's top executives.
The meetings took place in Boston and Chicago last week, involving AHR's CEO Danny Prosky, CFO Brian Peay, COO Gabe Willhite, and VP IR & Finance Alan Peterson. These discussions provided BofA Securities with a deeper understanding of the company's potential for internal growth, the robustness of the Trilogy platform, and the opportunities for external growth.
The firm expressed a positive outlook on the company's future, highlighting the anticipated benefits of the Trilogy platform to AHR's overall operations. The analyst from BofA Securities noted that these elements could lead to a revaluation of the stock as investors become more informed about the company's prospects.
Further, the analyst suggested that with increased investor awareness, American Healthcare REIT could achieve a higher Adjusted Funds From Operations (AFFO) multiple compared to its peers, such as Ventas Inc (NYSE:VTR). This optimism is based on the perceived value generation from the company's strategic initiatives and growth opportunities.
In other recent news, American Healthcare REIT has experienced several notable developments. Truist Securities recently adjusted its price target for the company to $17, up from $16, while retaining a Buy rating. The revised price target reflects a potential 24% total return, indicating confidence in the company's growth prospects. This is despite the firm maintaining its Funds from Operations (FFO) estimates for 2024 and 2025.
Analysts from various firms, including Barclays (LON:BARC) Capital Inc., JMP Securities, KeyBanc, and RBC Capital Markets, have given American Healthcare REIT an Overweight rating, highlighting the company's strategic positioning in the healthcare real estate market as a potential driver for Net Operating Income (NOI) growth. The company's same-store net operating income (SSNOI) growth is also tracking ahead of expectations, which could lead to an increase in 2024 Net Funds From Operations (NFFO) guidance.
In addition to these developments, American Healthcare REIT has announced the date for its 2024 annual meeting of stockholders and the deadline for stockholder proposals. The company's board of directors has established November 7, 2024, as the date for the upcoming annual meeting and set new deadlines for stockholder proposals.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.